Drugs that contain Morphine Sulfate; Naltrexone Hydrochloride

1. List of Embeda drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8685443 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Jul, 2025

(2 years from now)

US8685444 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Jul, 2025

(2 years from now)

US8846104 ALPHARMA PHARMS Pharmaceutical compositions for the deterrence and/or prevention of abuse
Jun, 2027

(4 years from now)

US8877247 ALPHARMA PHARMS Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
Jun, 2027

(4 years from now)

US7682633 ALPHARMA PHARMS Pharmaceutical composition
Jun, 2027

(4 years from now)

US7682634 ALPHARMA PHARMS Pharmaceutical compositions
Jun, 2027

(4 years from now)

US8158156 ALPHARMA PHARMS Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
Jun, 2027

(4 years from now)

US7815934 ALPHARMA PHARMS Sequestering subunit and related compositions and methods
Dec, 2027

(4 years from now)

US8623418 ALPHARMA PHARMS Pharmaceutical composition
Nov, 2029

(6 years from now)

Market Authorisation Date: 13 August, 2009

Treatment: Management of pain severe enough to require daily, around-the-clock, long term opioid treatment by orally administering a plurality of composite subunits as claimed; Management of pain severe enough to require daily, around-the-clock, long term opioid treatement by orally administering an intact composition as claimed.; Treatment of moderate to severe chronic pain by administering an intact composition as claimed

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of EMBEDA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic